V-OLA: point-of-care HIV viral load monitoring and drug resistance testing
V-OLA:即时 HIV 病毒载量监测和耐药性测试
基本信息
- 批准号:10179314
- 负责人:
- 金额:$ 70.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-14 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdoptionBindingBiological AssayBlindedCLIA certifiedChemistryClinicalCodon NucleotidesConsensusCounselingDNADetectionDevicesDrug TargetingDrug resistanceEngineeringEquipmentFailureGoalsHIVHIV drug resistanceHIV-1HourIndividualIntegraseLaboratoriesLateralLigationLinkMedicalMonitorMutationOligonucleotidesPatientsPeptide HydrolasesPerformancePharmaceutical PreparationsPlasmaPopulationPreparationProceduresProtocols documentationQuality ControlRNARNA-Directed DNA PolymeraseReagentReflex actionRegimenReportingResearchResistance developmentResourcesRiskSamplingScheduleSiteSpecimenSystemTemperatureTestingTimeTreatment FailureTubeViral Load resultViral load measurementVirusWhole BloodWorkacquired drug resistanceantiretroviral therapyaquariumbaseclinically relevantcostdesigndetection testdetectordigitaldrug testingexperienceimplementation studyinnovationinnovative technologiesinstrumentinternal controlisothermal amplificationlaboratory equipmentlateral flow assaymutantnext generation sequencingoperationpoint of carepreventrapid testresistance mutationscale uptest striptransmission processusability
项目摘要
ABSTRACT
We will develop the first test for detection of viral load (VL) and HIV drug resistance (DR) that is appropriate for
low-resource settings (LRS). This new test is based on years of experience developing and testing the
Oligonucleotide Ligation Assay (OLA) for HIV DR, as well as our recent work to develop OLA-Simple – a lab kit
that reduces the time and complexity of OLA, but still requires laboratory equipment, laboratory one-way
workflow to prevent contamination by amplicons, and hands-on operation of multiple steps. The proposed V-
OLA test is a major advance over OLA-Simple that uses innovative technologies coordinated to give a low-cost,
streamlined test suite appropriate for HIV patient management. We will develop rapid sample preparation from
whole blood, semi-quantitative VL measurement at clinically-relevant thresholds (current WHO cut-off for
treatment failure is >1000 copies/mL), and an integrated test cartridge to identify HIV DR mutations (goal to
detect 10% mutant for patients with VL >1000 copies/mL). In Aim 1, we will develop chemistry and sample
preparation format for HIV RNA isolation compatible with a rapid VL test. In Aim 2, we will develop the VL test
using semi-quantitative isothermal amplification, including a simple low-cost heat block and detector. In Aim 3,
we will develop core OLA chemistry including isothermal amplification of DR target regions, ligation on single-
stranded amplicon, and dry reagents for amplification and OLA; we will test assays on different HIV subtypes. In
Aim 4, we will develop the integrated DR detection device, including isothermal amplification and ligation with
lateral flow strip detection. In Aim 5, we will combine the VF and DR tests into a coordinated system including
refining hardware, scaling up fabrication of kit disposables, and develop a digitally-assisted system – called
Aquarium – to provide step-by-step guided protocols, sample tracking, results interpretation, and scheduled
quality control tests. We will test V-OLA on banked HIV plasma samples (HIV-1 subtypes of A, C, D, and AE).
This level of testing is intended to provide preliminary evidence for in-depth studies on performance, usability,
and implementation.
摘要
我们将开发第一种检测病毒载量(VL)和HIV耐药性(DR)的检测方法,
低资源环境(LRS)。这项新的测试是基于多年来开发和测试
用于HIV DR的寡核苷酸连接试验(奥拉),以及我们最近开发的OLA-Simple - a实验室试剂盒
这减少了奥拉的时间和复杂性,但仍然需要实验室设备,实验室单向
防止扩增子污染的工作流程,以及多个步骤的实际操作。建议的V-
奥拉测试是一个重大的进步,使用创新的技术协调,以提供一个低成本,
适合艾滋病毒患者管理的精简测试套件。我们将开发快速样品制备技术,
在临床相关阈值下的全血半定量VL测量(当前WHO截止值为
治疗失败>1000拷贝/mL),以及用于识别HIV DR突变的集成检测盒(目标是
对于VL >1000拷贝/mL的患者检测10%突变体)。在目标1中,我们将开发化学和样品
用于HIV RNA分离的制备形式与快速VL检测兼容。在目标2中,我们将开发VL测试
使用半定量等温扩增,包括简单的低成本加热块和检测器。在目标3中,
我们将开发核心奥拉化学,包括DR靶区域的等温扩增,
单链扩增子、用于扩增干试剂和奥拉;我们将对不同的HIV亚型进行检测。在
目的4:建立一套完整的DR检测装置,包括等温扩增和连接
侧流条带检测。在目标5中,我们将联合收割机将VF和DR测试组合到一个协调系统中,包括
改进硬件,扩大一次性套件的制造规模,并开发一个数字辅助系统-称为
水族馆-提供分步指导方案、样本跟踪、结果解释和预定
质量控制测试。我们将在库存HIV血浆样本(HIV-1亚型A、C、D和AE)上检测V-OLA。
此级别的测试旨在为性能、可用性、
和执行
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barry Ryan Lutz其他文献
Barry Ryan Lutz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barry Ryan Lutz', 18)}}的其他基金
Transrenal DNA for point-of-care diagnosis of TB
用于结核病即时诊断的经肾 DNA
- 批准号:
10285973 - 财政年份:2021
- 资助金额:
$ 70.61万 - 项目类别:
Transrenal DNA for point-of-care diagnosis of TB
用于结核病即时诊断的经肾 DNA
- 批准号:
10443886 - 财政年份:2021
- 资助金额:
$ 70.61万 - 项目类别:
Engineering a denaturant-resistant polymerase for direct nucleic acid diagnostics
设计用于直接核酸诊断的抗变性聚合酶
- 批准号:
10308721 - 财政年份:2020
- 资助金额:
$ 70.61万 - 项目类别:
V-OLA: point-of-care HIV viral load monitoring and drug resistance testing
V-OLA:即时 HIV 病毒载量监测和耐药性测试
- 批准号:
10407553 - 财政年份:2019
- 资助金额:
$ 70.61万 - 项目类别:
V-OLA: point-of-care HIV viral load monitoring and drug resistance testing
V-OLA:即时 HIV 病毒载量监测和耐药性测试
- 批准号:
10655323 - 财政年份:2019
- 资助金额:
$ 70.61万 - 项目类别:
HIV-specific target capture and quantitative isothermal amplification for acute HIV diagnosis and treatment monitoring
HIV 特异性目标捕获和定量等温扩增,用于急性 HIV 诊断和治疗监测
- 批准号:
10471460 - 财政年份:2018
- 资助金额:
$ 70.61万 - 项目类别:
HIV-specific target capture and quantitative isothermal amplification for acute HIV diagnosis and treatment monitoring
HIV 特异性目标捕获和定量等温扩增,用于急性 HIV 诊断和治疗监测
- 批准号:
9975694 - 财政年份:2018
- 资助金额:
$ 70.61万 - 项目类别:
HIV-specific target capture and quantitative isothermal amplification for acute HIV diagnosis and treatment monitoring
HIV 特异性目标捕获和定量等温扩增,用于急性 HIV 诊断和治疗监测
- 批准号:
10423662 - 财政年份:2018
- 资助金额:
$ 70.61万 - 项目类别:
Point-of-care diagnosis of pulmonary TB from urine samples
通过尿液样本即时诊断肺结核
- 批准号:
9166566 - 财政年份:2016
- 资助金额:
$ 70.61万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 70.61万 - 项目类别:
Fellowship Programs